Cape Verde vs Qatar: Cause of death, by non-communicable diseases, ages 15-59
Cape Verde
50.2%
in 2021
Qatar
49.4%
in 2021
Cape Verde rank
105th
Qatar rank
108th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Cape Verde
- Qatar
How they compare
Cape Verde currently reports 50.2% against 49.4% in Qatar, a difference of 0.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Qatar ahead.
Cape Verde ranks 105th and Qatar ranks 108th of 185 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cape Verde | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.5% | 63.4% | 21.9% | Qatar |
| 2010s | 51.2% | 60.4% | 9.2% | Qatar |
| 2020s | 50.8% | 53.3% | 2.6% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Cape Verde or Qatar?
- Cape Verde, at 50.2% against 49.4% in Qatar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Cape Verde and Qatar?
- 0.8%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Qatar?
- 6 years are reported by both, from 2000 to 2021.
- How do Cape Verde and Qatar rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Cape Verde ranks 105th and Qatar ranks 108th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.